Pfenex to Develop an Anti-Malaria Agent - NBC 7 San Diego
Ignite San Diego

Ignite San Diego

Local business spotlight

Pfenex to Develop an Anti-Malaria Agent



    Three ways La Jolla UTC delivers on what employees really want

    San Diego-based Pfenex Inc. has received a subcontract from Reston, Va.-based defense contractor Leidos Holdings Inc. to develop an anti-malaria agent. The companies did not disclose the amount of the subcontract.

    This is the second contract that Pfenex, a privately held company, has received from Leidos (NYSE: LDOS) to develop anti-malarials.

    The subcontract is funded with federal funds from Leidos' prime Malaria Vaccine Production and Support Services contract from the National Institute of Allergy and Infectious Diseases.

    Earlier this month, Pfenex received an $8 million extension of its $23.9 million contract with the U.S. Department of Health and Human Services to develop an anthrax vaccine.

    The Business Journal is the premier business publication in San Diego. Every day online and each Monday in print, the Business Journal reports on how local business operate and why businesses leaders make the decisions they do. Every story is a dose of insight into how to run a better, more efficient, more profitable business.